Artisan Partners Limited Partnership Compugen LTD Transaction History

Artisan Partners Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $30,181 - $64,015	-19,224 Reduced 2.36%	794,161 $1.47 Million
Q1 2022 May 13, 2022	BUY	$2.76 - $4.64 $44,866 - $75,427	16,256 Added 2.04%	813,385 $2.62 Million
Q4 2021 Feb 11, 2022	SELL	$4.09 - $7.16 $23,509 - $41,155	-5,748 Reduced 0.72%	797,129 $3.43 Million
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $259,445 - $358,750	44,732 Added 5.9%	802,877 $4.79 Million
Q2 2021 Aug 12, 2021	BUY	$6.87 - $9.16 $16,220 - $21,626	2,361 Added 0.31%	758,145 $6.28 Million
Q1 2021 May 11, 2021	BUY	$7.67 - $13.77 $48,535 - $87,136	6,328 Added 0.84%	755,784 $6.49 Million
Q4 2020 Feb 10, 2021	BUY	$12.07 - $17.95 $1.99 Million - $2.95 Million	164,518 Added 28.13%	749,456 $9.08 Million
Q3 2020 Nov 12, 2020	BUY	$14.16 - $19.45 $1.76 Million - $2.42 Million	124,322 Added 26.99%	584,938 $9.51 Million
Q2 2020 Aug 12, 2020	BUY	$6.97 - $17.12 $3.21 Million - $7.89 Million	460,616 New	460,616 $6.92 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.